The objective of this study was to collect information regarding hoof care professionals’ billing practices and to gather their opinions about hoof diseases and the value of lameness prevention. Responses were gathered from hoof trimmers through both online (n = 5) and paper (n = 111) survey platforms. Of the 6 hoof diseases included in the survey, the treatment cost per case was greatest for toe ulcers ($20 ± 9.5), sole ulcers ($20 ± 8.6), white line disease ($20 ± 8.1), and thin soles ($18 ± 8.1), and least for infectious diseases (foot rot and digital dermatitis; $8 ± 7.6 and $8 ± 9.6, respectively). Of these diseases, digital dermatitis represented the largest portion of the lameness cases treated by respondents over the past year (44 ± 20.4%) whereas toe ulcers and thin soles represented the least (5 ± 4.1% and 5 ± 5.7%, respectively). Respondents that served mostly large herds (>500 lactating cows) reported a lower prevalence of digital dermatitis (32 ± 4.2% vs. 44 ± 3.4% and 47 ± 3.2% in small and medium herds, respectively) and a higher prevalence of sole ulcers (23 ± 3.0% vs. 13 ± 2.3% and 13 ± 2.4% in small and medium herds, respectively). Region of the US (Northeast, Midwest, or Other) also influenced hoof disease prevalence; respondents from the Northeast reported more sole ulcers than respondents from Other regions (22 ± 2.3% vs. 12 ± 3.3%). When respondents were asked their opinion on which disease was associated with the greatest total cost per case to the producer (e.g., treatment and labor costs plus the reduction in milk yield, reduced reproductive performance), digital dermatitis was ranked as having the greatest and thin soles as having the lowest total cost per case. Finally, respondents indicated that the most important benefits of reducing lameness were enhanced animal welfare and increased milk production whereas the least important benefit was reduced veterinary and hoof trimmer fees. Results from this survey can be used to improve the accuracy of hoof disease cost estimates and contribute to better decision-making regarding both lameness treatment and prevention.